| NCT ID | NCT07458581 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Federal University of Vicosa |
| Condition | Tactical Index |
| Study Type | INTERVENTIONAL |
| Enrollment | 26 participants |
| Start Date | 2026-05 |
| Primary Completion | 2026-07 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 26 participants in total. It began in 2026-05 with a primary completion date of 2026-07.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This randomized controlled trial evaluates whether adding a short, structured team-reflection protocol (Tactical Programme for Critical Thinking, TPCT) to regular elite women's underwater rugby training improves tactical efficiency. Both groups complete the same training content and time; the TPCT group uses brief guided discussion during recovery intervals, while the control group uses the same time for passive recovery. Tactical efficiency is assessed using video-recorded 3v3 scrimmages coded with the RUSTAC checklist at baseline and after 6 weeks.
Eligibility Criteria
Inclusion Criteria: * Female elite underwater rugby players aged ≥18 years. * Officially rostered members of the participating high-performance team/squad. * Regular training participation (minimum 2 sessions per week) in the team's programme. * Able to complete study procedures at Baseline (Visit 1) and Post-intervention at 6 weeks (Visit 2), including standardized 3v3 scrimmage video assessment. * Willing and able to provide written informed consent. Exclusion Criteria: * Current injury, illness, or medical condition that prevents full participation in regular underwater rugby training during the intervention period. * Anticipated prolonged absence (e.g., travel/competing/other commitments) that would prevent meaningful exposure to the intervention dose (e.g., missing \>20% of sessions). * Inability to complete the assessment procedures reliably (e.g., unable to participate in the standardized 3v3 assessment or comply with study instructions). * Declines participation or withdraws consent.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07458581 clinical trial?
This trial is open to female participants only, aged 18 Years or older, studying Tactical Index. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07458581 currently recruiting?
Yes, NCT07458581 is actively recruiting participants. Contact the research team at samuel.gaviria@tdea.edu.co for enrollment information.
Where is the NCT07458581 trial being conducted?
This trial is being conducted at Medellín, Colombia.
Who is sponsoring the NCT07458581 clinical trial?
NCT07458581 is sponsored by Federal University of Vicosa. The trial plans to enroll 26 participants.